Condition: Endometrial Cancer · Sponsor: University Hospital, Gasthuisberg
EUGENIE is a prospective multicentre interventional study, focused on improving endometrial cancer (EC) assessment by combining the new technique of genomic profiling with surgical extra uterine disease assessment. The investigators aim to correlate EC stage to each of the molecular subgroups of disease and thereby guide surgical treatment and staging of EC by determining the association between molecular classification and disease stage and evaluating if and how disease stage in each of the molecular subgroups associates with prognosis.
This description comes directly from the study's public registry record.
Frédéric Amant, MD, PhD · +3216342194 · frederic.amant@uzleuven.be
Ayaka Wakatsuki, Msc · +3216344169 · ayaka.wakatsuki@uzleuven.be
Always discuss trial participation with your own doctor first.
| UZ Gasthuisberg, Katholieke Universiteit Leuven | Leuven, Belgium | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06354738